Loading…

The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society

Summary Extracorporeal photopheresis (ECP) has been used for over 35 years in the treatment of erythrodermic cutaneous T‐cell lymphoma (CTCL) and over 20 years for chronic and acute graft‐versus‐host disease (GvHD) and solid organ transplant rejection. ECP for CTCL and GvHD is available at specialis...

Full description

Saved in:
Bibliographic Details
Published in:British journal of haematology 2017-04, Vol.177 (2), p.287-310
Main Authors: Alfred, Arun, Taylor, Peter C., Dignan, Fiona, El‐Ghariani, Khaled, Griffin, James, Gennery, Andrew R., Bonney, Denise, Das‐Gupta, Emma, Lawson, Sarah, Malladi, Ram K., Douglas, Kenneth W., Maher, Tracey, Guest, Julie, Hartlett, Laura, Fisher, Andrew J., Child, Fiona, Scarisbrick, Julia J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4767-b761f988ded2d1fe8e43c74e2c6dfc2656a7943453824928c0af9194301d6cf13
cites cdi_FETCH-LOGICAL-c4767-b761f988ded2d1fe8e43c74e2c6dfc2656a7943453824928c0af9194301d6cf13
container_end_page 310
container_issue 2
container_start_page 287
container_title British journal of haematology
container_volume 177
creator Alfred, Arun
Taylor, Peter C.
Dignan, Fiona
El‐Ghariani, Khaled
Griffin, James
Gennery, Andrew R.
Bonney, Denise
Das‐Gupta, Emma
Lawson, Sarah
Malladi, Ram K.
Douglas, Kenneth W.
Maher, Tracey
Guest, Julie
Hartlett, Laura
Fisher, Andrew J.
Child, Fiona
Scarisbrick, Julia J.
description Summary Extracorporeal photopheresis (ECP) has been used for over 35 years in the treatment of erythrodermic cutaneous T‐cell lymphoma (CTCL) and over 20 years for chronic and acute graft‐versus‐host disease (GvHD) and solid organ transplant rejection. ECP for CTCL and GvHD is available at specialised centres across the UK. The lack of prospective randomised trials in ECP led to the development of UK Consensus Statements for patient selection, treatment schedules, monitoring protocols and patient assessment criteria for ECP. The recent literature has been reviewed and considered when writing this update. Most notably, the national transition from the UVAR XTS® machine to the new CELLEX machine for ECP with dual access and a shorter treatment time has led to relevant changes in these schedules. This consensus statement updates the previous statement from 2007 on the treatment of CTCL and GvHD with ECP using evidence based medicine and best medical practise and includes guidelines for both children and adults.
doi_str_mv 10.1111/bjh.14537
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5412836</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1891861371</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4767-b761f988ded2d1fe8e43c74e2c6dfc2656a7943453824928c0af9194301d6cf13</originalsourceid><addsrcrecordid>eNqNks1u1DAUhSMEokNhwQsgS2yoRFpfx_nrAolWQIFKIDFdWx7nZuJRYgfbKcyOR-Dt2PMkeJpSUSQkvLF1_d3j46ObJI-BHkJcR6tNdwg8z8o7yQKyIk8ZcLibLCilZQqUV3vJA-83lEJGc7if7LGKMVpnsEh-LDskzvZIbEvwa3BSWTdah7InY2eDHTt06LUn2pAQ2UEaucYBTdh1qClIg3byZPnz23eFfU_67RAbB_mcrJ1sQyxfovOTj4fO-kAa7VF6JNI0xLq1jLJOGj_2Mko63KAK2ppjIomyxqOJrcQHGeY3p7GJR9I6O1zZuXhPPt6y-ckqjWH7MLnXyt7jo-t9P7l4_Wp5epaef3jz9vTleap4WZTpqiygrauqwYY10GKFPFMlR6aKplWsyAtZ1jyL2VaM16xSVLY1xAqFplAtZPvJi1l3nFYDNip6dLIXo9ODdFthpRa3b4zuxNpeipwDq7IiCjy7FnD284Q-iEH7XZBzrgKqGqoCshL-Ay1pwXn0F9Gnf6EbOzkTkxBQM8rzGjiP1MFMKWe9d9je-AYqdpMl4mSJq8mK7JM_P3pD_h6lCBzNwBfd4_bfSuLk3dks-QvlXuCb</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1920459144</pqid></control><display><type>article</type><title>The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Alfred, Arun ; Taylor, Peter C. ; Dignan, Fiona ; El‐Ghariani, Khaled ; Griffin, James ; Gennery, Andrew R. ; Bonney, Denise ; Das‐Gupta, Emma ; Lawson, Sarah ; Malladi, Ram K. ; Douglas, Kenneth W. ; Maher, Tracey ; Guest, Julie ; Hartlett, Laura ; Fisher, Andrew J. ; Child, Fiona ; Scarisbrick, Julia J.</creator><creatorcontrib>Alfred, Arun ; Taylor, Peter C. ; Dignan, Fiona ; El‐Ghariani, Khaled ; Griffin, James ; Gennery, Andrew R. ; Bonney, Denise ; Das‐Gupta, Emma ; Lawson, Sarah ; Malladi, Ram K. ; Douglas, Kenneth W. ; Maher, Tracey ; Guest, Julie ; Hartlett, Laura ; Fisher, Andrew J. ; Child, Fiona ; Scarisbrick, Julia J.</creatorcontrib><description>Summary Extracorporeal photopheresis (ECP) has been used for over 35 years in the treatment of erythrodermic cutaneous T‐cell lymphoma (CTCL) and over 20 years for chronic and acute graft‐versus‐host disease (GvHD) and solid organ transplant rejection. ECP for CTCL and GvHD is available at specialised centres across the UK. The lack of prospective randomised trials in ECP led to the development of UK Consensus Statements for patient selection, treatment schedules, monitoring protocols and patient assessment criteria for ECP. The recent literature has been reviewed and considered when writing this update. Most notably, the national transition from the UVAR XTS® machine to the new CELLEX machine for ECP with dual access and a shorter treatment time has led to relevant changes in these schedules. This consensus statement updates the previous statement from 2007 on the treatment of CTCL and GvHD with ECP using evidence based medicine and best medical practise and includes guidelines for both children and adults.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.14537</identifier><identifier>PMID: 28220931</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Children ; Clinical trials ; Consensus ; cutaneous T‐cell lymphoma ; extracorporeal photopheresis ; Graft rejection ; Graft Rejection - therapy ; Graft vs Host Disease - therapy ; Graft-versus-host reaction ; graft‐versus‐host disease ; Hematology ; Humans ; Lymphocytes T ; Lymphoma ; Lymphoma, T-Cell, Cutaneous - therapy ; Photopheresis - methods ; rejection ; Research Paper ; Reviews ; Schedules ; T-cell lymphoma ; Transplantation ; treatment protocol ; United Kingdom</subject><ispartof>British journal of haematology, 2017-04, Vol.177 (2), p.287-310</ispartof><rights>2017 The Authors. published by John Wiley &amp; Sons Ltd.</rights><rights>2017 The Authors. British Journal of Haematology published by John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2017 John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4767-b761f988ded2d1fe8e43c74e2c6dfc2656a7943453824928c0af9194301d6cf13</citedby><cites>FETCH-LOGICAL-c4767-b761f988ded2d1fe8e43c74e2c6dfc2656a7943453824928c0af9194301d6cf13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28220931$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alfred, Arun</creatorcontrib><creatorcontrib>Taylor, Peter C.</creatorcontrib><creatorcontrib>Dignan, Fiona</creatorcontrib><creatorcontrib>El‐Ghariani, Khaled</creatorcontrib><creatorcontrib>Griffin, James</creatorcontrib><creatorcontrib>Gennery, Andrew R.</creatorcontrib><creatorcontrib>Bonney, Denise</creatorcontrib><creatorcontrib>Das‐Gupta, Emma</creatorcontrib><creatorcontrib>Lawson, Sarah</creatorcontrib><creatorcontrib>Malladi, Ram K.</creatorcontrib><creatorcontrib>Douglas, Kenneth W.</creatorcontrib><creatorcontrib>Maher, Tracey</creatorcontrib><creatorcontrib>Guest, Julie</creatorcontrib><creatorcontrib>Hartlett, Laura</creatorcontrib><creatorcontrib>Fisher, Andrew J.</creatorcontrib><creatorcontrib>Child, Fiona</creatorcontrib><creatorcontrib>Scarisbrick, Julia J.</creatorcontrib><title>The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>Summary Extracorporeal photopheresis (ECP) has been used for over 35 years in the treatment of erythrodermic cutaneous T‐cell lymphoma (CTCL) and over 20 years for chronic and acute graft‐versus‐host disease (GvHD) and solid organ transplant rejection. ECP for CTCL and GvHD is available at specialised centres across the UK. The lack of prospective randomised trials in ECP led to the development of UK Consensus Statements for patient selection, treatment schedules, monitoring protocols and patient assessment criteria for ECP. The recent literature has been reviewed and considered when writing this update. Most notably, the national transition from the UVAR XTS® machine to the new CELLEX machine for ECP with dual access and a shorter treatment time has led to relevant changes in these schedules. This consensus statement updates the previous statement from 2007 on the treatment of CTCL and GvHD with ECP using evidence based medicine and best medical practise and includes guidelines for both children and adults.</description><subject>Children</subject><subject>Clinical trials</subject><subject>Consensus</subject><subject>cutaneous T‐cell lymphoma</subject><subject>extracorporeal photopheresis</subject><subject>Graft rejection</subject><subject>Graft Rejection - therapy</subject><subject>Graft vs Host Disease - therapy</subject><subject>Graft-versus-host reaction</subject><subject>graft‐versus‐host disease</subject><subject>Hematology</subject><subject>Humans</subject><subject>Lymphocytes T</subject><subject>Lymphoma</subject><subject>Lymphoma, T-Cell, Cutaneous - therapy</subject><subject>Photopheresis - methods</subject><subject>rejection</subject><subject>Research Paper</subject><subject>Reviews</subject><subject>Schedules</subject><subject>T-cell lymphoma</subject><subject>Transplantation</subject><subject>treatment protocol</subject><subject>United Kingdom</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNqNks1u1DAUhSMEokNhwQsgS2yoRFpfx_nrAolWQIFKIDFdWx7nZuJRYgfbKcyOR-Dt2PMkeJpSUSQkvLF1_d3j46ObJI-BHkJcR6tNdwg8z8o7yQKyIk8ZcLibLCilZQqUV3vJA-83lEJGc7if7LGKMVpnsEh-LDskzvZIbEvwa3BSWTdah7InY2eDHTt06LUn2pAQ2UEaucYBTdh1qClIg3byZPnz23eFfU_67RAbB_mcrJ1sQyxfovOTj4fO-kAa7VF6JNI0xLq1jLJOGj_2Mko63KAK2ppjIomyxqOJrcQHGeY3p7GJR9I6O1zZuXhPPt6y-ckqjWH7MLnXyt7jo-t9P7l4_Wp5epaef3jz9vTleap4WZTpqiygrauqwYY10GKFPFMlR6aKplWsyAtZ1jyL2VaM16xSVLY1xAqFplAtZPvJi1l3nFYDNip6dLIXo9ODdFthpRa3b4zuxNpeipwDq7IiCjy7FnD284Q-iEH7XZBzrgKqGqoCshL-Ay1pwXn0F9Gnf6EbOzkTkxBQM8rzGjiP1MFMKWe9d9je-AYqdpMl4mSJq8mK7JM_P3pD_h6lCBzNwBfd4_bfSuLk3dks-QvlXuCb</recordid><startdate>201704</startdate><enddate>201704</enddate><creator>Alfred, Arun</creator><creator>Taylor, Peter C.</creator><creator>Dignan, Fiona</creator><creator>El‐Ghariani, Khaled</creator><creator>Griffin, James</creator><creator>Gennery, Andrew R.</creator><creator>Bonney, Denise</creator><creator>Das‐Gupta, Emma</creator><creator>Lawson, Sarah</creator><creator>Malladi, Ram K.</creator><creator>Douglas, Kenneth W.</creator><creator>Maher, Tracey</creator><creator>Guest, Julie</creator><creator>Hartlett, Laura</creator><creator>Fisher, Andrew J.</creator><creator>Child, Fiona</creator><creator>Scarisbrick, Julia J.</creator><general>Blackwell Publishing Ltd</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201704</creationdate><title>The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society</title><author>Alfred, Arun ; Taylor, Peter C. ; Dignan, Fiona ; El‐Ghariani, Khaled ; Griffin, James ; Gennery, Andrew R. ; Bonney, Denise ; Das‐Gupta, Emma ; Lawson, Sarah ; Malladi, Ram K. ; Douglas, Kenneth W. ; Maher, Tracey ; Guest, Julie ; Hartlett, Laura ; Fisher, Andrew J. ; Child, Fiona ; Scarisbrick, Julia J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4767-b761f988ded2d1fe8e43c74e2c6dfc2656a7943453824928c0af9194301d6cf13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Children</topic><topic>Clinical trials</topic><topic>Consensus</topic><topic>cutaneous T‐cell lymphoma</topic><topic>extracorporeal photopheresis</topic><topic>Graft rejection</topic><topic>Graft Rejection - therapy</topic><topic>Graft vs Host Disease - therapy</topic><topic>Graft-versus-host reaction</topic><topic>graft‐versus‐host disease</topic><topic>Hematology</topic><topic>Humans</topic><topic>Lymphocytes T</topic><topic>Lymphoma</topic><topic>Lymphoma, T-Cell, Cutaneous - therapy</topic><topic>Photopheresis - methods</topic><topic>rejection</topic><topic>Research Paper</topic><topic>Reviews</topic><topic>Schedules</topic><topic>T-cell lymphoma</topic><topic>Transplantation</topic><topic>treatment protocol</topic><topic>United Kingdom</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alfred, Arun</creatorcontrib><creatorcontrib>Taylor, Peter C.</creatorcontrib><creatorcontrib>Dignan, Fiona</creatorcontrib><creatorcontrib>El‐Ghariani, Khaled</creatorcontrib><creatorcontrib>Griffin, James</creatorcontrib><creatorcontrib>Gennery, Andrew R.</creatorcontrib><creatorcontrib>Bonney, Denise</creatorcontrib><creatorcontrib>Das‐Gupta, Emma</creatorcontrib><creatorcontrib>Lawson, Sarah</creatorcontrib><creatorcontrib>Malladi, Ram K.</creatorcontrib><creatorcontrib>Douglas, Kenneth W.</creatorcontrib><creatorcontrib>Maher, Tracey</creatorcontrib><creatorcontrib>Guest, Julie</creatorcontrib><creatorcontrib>Hartlett, Laura</creatorcontrib><creatorcontrib>Fisher, Andrew J.</creatorcontrib><creatorcontrib>Child, Fiona</creatorcontrib><creatorcontrib>Scarisbrick, Julia J.</creatorcontrib><collection>Wiley Online Library website</collection><collection>Wiley Online Library Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alfred, Arun</au><au>Taylor, Peter C.</au><au>Dignan, Fiona</au><au>El‐Ghariani, Khaled</au><au>Griffin, James</au><au>Gennery, Andrew R.</au><au>Bonney, Denise</au><au>Das‐Gupta, Emma</au><au>Lawson, Sarah</au><au>Malladi, Ram K.</au><au>Douglas, Kenneth W.</au><au>Maher, Tracey</au><au>Guest, Julie</au><au>Hartlett, Laura</au><au>Fisher, Andrew J.</au><au>Child, Fiona</au><au>Scarisbrick, Julia J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2017-04</date><risdate>2017</risdate><volume>177</volume><issue>2</issue><spage>287</spage><epage>310</epage><pages>287-310</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><abstract>Summary Extracorporeal photopheresis (ECP) has been used for over 35 years in the treatment of erythrodermic cutaneous T‐cell lymphoma (CTCL) and over 20 years for chronic and acute graft‐versus‐host disease (GvHD) and solid organ transplant rejection. ECP for CTCL and GvHD is available at specialised centres across the UK. The lack of prospective randomised trials in ECP led to the development of UK Consensus Statements for patient selection, treatment schedules, monitoring protocols and patient assessment criteria for ECP. The recent literature has been reviewed and considered when writing this update. Most notably, the national transition from the UVAR XTS® machine to the new CELLEX machine for ECP with dual access and a shorter treatment time has led to relevant changes in these schedules. This consensus statement updates the previous statement from 2007 on the treatment of CTCL and GvHD with ECP using evidence based medicine and best medical practise and includes guidelines for both children and adults.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>28220931</pmid><doi>10.1111/bjh.14537</doi><tpages>24</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1048
ispartof British journal of haematology, 2017-04, Vol.177 (2), p.287-310
issn 0007-1048
1365-2141
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5412836
source Wiley-Blackwell Read & Publish Collection
subjects Children
Clinical trials
Consensus
cutaneous T‐cell lymphoma
extracorporeal photopheresis
Graft rejection
Graft Rejection - therapy
Graft vs Host Disease - therapy
Graft-versus-host reaction
graft‐versus‐host disease
Hematology
Humans
Lymphocytes T
Lymphoma
Lymphoma, T-Cell, Cutaneous - therapy
Photopheresis - methods
rejection
Research Paper
Reviews
Schedules
T-cell lymphoma
Transplantation
treatment protocol
United Kingdom
title The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T13%3A03%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20extracorporeal%20photopheresis%20in%20the%20management%20of%20cutaneous%20T%E2%80%90cell%20lymphoma,%20graft%E2%80%90versus%E2%80%90host%20disease%20and%20organ%20transplant%20rejection:%20a%20consensus%20statement%20update%20from%20the%20UK%20Photopheresis%20Society&rft.jtitle=British%20journal%20of%20haematology&rft.au=Alfred,%20Arun&rft.date=2017-04&rft.volume=177&rft.issue=2&rft.spage=287&rft.epage=310&rft.pages=287-310&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1111/bjh.14537&rft_dat=%3Cproquest_pubme%3E1891861371%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4767-b761f988ded2d1fe8e43c74e2c6dfc2656a7943453824928c0af9194301d6cf13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1920459144&rft_id=info:pmid/28220931&rfr_iscdi=true